SPHERA FUNDS MANAGEMENT LTD. - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q1 2024$1,777,497
-60.3%
44,841
-80.9%
0.25%
-65.3%
Q4 2023$4,476,069
+117.2%
234,841
+30.5%
0.72%
+92.0%
Q3 2023$2,061,000
+0.2%
180,000
-10.0%
0.38%
+16.8%
Q2 2023$2,056,000
+33.2%
200,0000.0%0.32%
+24.4%
Q1 2023$1,544,000
+5.0%
200,0000.0%0.26%
-18.1%
Q4 2022$1,470,000
+2.1%
200,0000.0%0.32%
+57.5%
Q3 2022$1,440,000
-31.5%
200,000
+0.9%
0.20%
+24.2%
Q1 2021$2,102,000
-15.9%
198,2600.0%0.16%
-27.5%
Q4 2020$2,498,000
+43.3%
198,2600.0%0.22%
+29.8%
Q3 2020$1,743,000198,2600.17%
Other shareholders

There were no reported owners of ALPINE IMMUNE SCIENCES INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of ALPINE IMMUNE SCIENCES INC shareholders